• Explore /
  • Poster
  • / Updated survival outcomes of NEJ005/TCOG0902, a randomized phase II study of concurrent (C) versus sequential alternating (S) gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive epidermal growth factor receptor (<em>EGFR</em>) mutations.

Updated survival outcomes of NEJ005/TCOG0902, a randomized phase II study of concurrent (C) versus sequential alternating (S) gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive epidermal growth factor receptor (EGFR) mutations.

Abstract Poster

Authors

null

Satoshi Oizumi

Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan

Satoshi Oizumi , Shunichi Sugawara , Koichi Minato , Toshiyuki Harada , Akira Inoue , Yuka Fujita , Makoto Maemondo , Satoshi Watanabe , Kazuhiko Ito , Akihiko Gemma , Yoshiki Demura , Masao Harada , Hiroshi Isobe , Ichiro Kinoshita , Satoshi Morita , Kunihiko Kobayashi , Koichi Hagiwara , Minoru Kurihara , Toshihiro Nukiwa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

UMIN000002789

Citation

J Clin Oncol 35, 2017 (suppl; abstr 9038)

DOI

10.1200/JCO.2017.35.15_suppl.9038

Abstract #

9038

Poster Bd #

364

Abstract Disclosures

Similar Posters

First Author: Eisaku Miyauchi

First Author: Satoshi Oizumi

First Author: Si-Yu Wang

First Author: Yuki Sato